UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Integrins in T Cell Physiology

International journal of molecular sciences, 2018-02, Vol.19 (2), p.485

2018

Volltextzugriff (PDF)

Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma

Molecular cancer therapeutics, 2008-08, Vol.7 (8), p.2476-2485

2008

Volltextzugriff (PDF)

Involvement of autophagy in ovarian cancer: a working hypothesis

Journal of ovarian research, 2012-09, Vol.5 (1), p.22-22, Article 22

2012

Volltextzugriff (PDF)

PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells

Journal of molecular endocrinology, 2014-10, Vol.53 (2), p.247-258

2014

Volltextzugriff (PDF)

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression

International journal of clinical oncology, 2018-04, Vol.23 (2), p.281-286

2018

Volltextzugriff (PDF)

PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration

Genes & cancer, 2014-07, Vol.5 (7-8), p.226-239

2014

Volltextzugriff (PDF)

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

The New England journal of medicine, 2018-04, Vol.378 (15), p.1408-1418

2018

Volltextzugriff (PDF)

Ethics of appropriateness, in oncology and medicine

Clinical management issues, 2007-06, Vol.1 (2), p.43-44

Alabiso, Oscar

2007

Volltextzugriff (PDF)

Venous thromboembolism in non-small cell lung cancer patients: retrospective analysis of cases treated at the Oncology Day Hospital of Novara, Italy

Italian journal of medicine, 2013-01, Vol.7 (2), p.113-117

2013

Volltextzugriff (PDF)

Autophagy and thyroid carcinogenesis: genetic and epigenetic links

Endocrine-related cancer, 2014-02, Vol.21 (1), p.R13-R29

2014

Volltextzugriff (PDF)

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

The lancet oncology, 2018-04, Vol.19 (4), p.474-485

2018

Volltextzugriff (PDF)

Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report

The journal of vascular access, 2017-07, Vol.18 (4), p.325-327

2017

Volltextzugriff (PDF)

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial

Clinical colorectal cancer, 2020-12, Vol.19 (4), p.270-276

2020

Volltextzugriff (PDF)

Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients

Endocrine, 2016-12, Vol.54 (3), p.830-833

2016

Volltextzugriff (PDF)

FISH in triple-negative breast cancer: a possible strategy for the future?

Future oncology (London, England), 2015-04, Vol.11 (7), p.1023-1026

2015

Volltextzugriff (PDF)

Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab based regimen (ObservEr study)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14600-e14600

2014

Volltextzugriff (PDF)

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

Annals of oncology, 2015-04, Vol.26 (4), p.822-825

2015

Volltextzugriff (PDF)

Management of skin toxicity and cetuximab-based regimen compliance in first-line chemotherapy of metastatic colorectal cancer (mCRC) patients (pts): Results of observer study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e14557-e14557

2013

Volltextzugriff (PDF)

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Journal of translational medicine, 2016-07, Vol.14 (1), p.65-65, Article 65

2016

Volltextzugriff (PDF)

Prostate cancer and androgen deprivation therapy: Metabolic, cardiovascular and psychological side effects

Acta medica international, 2016-07, Vol.3 (2), p.158

2016

Volltextzugriff (PDF)

TAILOR: A phase III trial comparing erlotinib with docetaxel as the second-line treatment of NSCLC patients with wild-type (wt) EGFR

Journal of clinical oncology, 2012-06, Vol.30 (18_suppl), p.LBA7501-LBA7501

2012

Volltextzugriff (PDF)

TAILOR: Phase III trial comparing erlotinib with docetaxel in the second-line treatment of NSCLC patients with wild-type (wt) EGFR

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.LBA7501-LBA7501

2012

Volltextzugriff (PDF)

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Annals of oncology, 2019-05, Vol.30 (5), p.766

2019

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)
Berichte
(1)

Sprache

Englisch
(31)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Oncology
(10)
Humans
(9)
Autophagy
(4)
Chemotherapy
(4)
Endocrinology & Metabolism
(4)
Metastases
(3)
Patients
(3)
Review
(3)
Aged
(2)
Androgens
(2)
Animals
(2)
Anticancer Drugs
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Breast Cancer
(2)
Cancer
(2)
Cancer Research
(2)
Cell Line, Tumor
(2)
Disparity
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrins in T Cell Physiology

Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma

Involvement of autophagy in ovarian cancer: a working hypothesis

PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression

PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Ethics of appropriateness, in oncology and medicine

Venous thromboembolism in non-small cell lung cancer patients: retrospective analysis of cases treated at the Oncology Day Hospital of Novara, Italy

Autophagy and thyroid carcinogenesis: genetic and epigenetic links

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial

Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients

FISH in triple-negative breast cancer: a possible strategy for the future?

Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab based regimen (ObservEr study)

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

Management of skin toxicity and cetuximab-based regimen compliance in first-line chemotherapy of metastatic colorectal cancer (mCRC) patients (pts): Results of observer study

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Prostate cancer and androgen deprivation therapy: Metabolic, cardiovascular and psychological side effects

TAILOR: A phase III trial comparing erlotinib with docetaxel as the second-line treatment of NSCLC patients with wild-type (wt) EGFR

TAILOR: Phase III trial comparing erlotinib with docetaxel in the second-line treatment of NSCLC patients with wild-type (wt) EGFR

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM)

Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM)

Aktive Filter

Suchergebnisse filtern